234 related articles for article (PubMed ID: 27199222)
1. Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastases.
Thorn M; Guha P; Cunetta M; Espat NJ; Miller G; Junghans RP; Katz SC
Cancer Gene Ther; 2016 Jun; 23(6):188-98. PubMed ID: 27199222
[TBL] [Abstract][Full Text] [Related]
2. Oncolytic virus-mediated reducing of myeloid-derived suppressor cells enhances the efficacy of PD-L1 blockade in gemcitabine-resistant pancreatic cancer.
Kajiwara Y; Tazawa H; Yamada M; Kanaya N; Fushimi T; Kikuchi S; Kuroda S; Ohara T; Noma K; Yoshida R; Umeda Y; Urata Y; Kagawa S; Fujiwara T
Cancer Immunol Immunother; 2023 May; 72(5):1285-1300. PubMed ID: 36436021
[TBL] [Abstract][Full Text] [Related]
3. Combination Immunotherapy of Oncolytic Flu-Vectored Virus and Programmed Cell Death 1 Blockade Enhances Antitumor Activity in Hepatocellular Carcinoma.
Yu H; Sun F; Xu Y; Yang H; Tian C; Li C; Kang Y; Hao L; Yang P
Hum Gene Ther; 2024 Mar; 35(5-6):177-191. PubMed ID: 38386514
[TBL] [Abstract][Full Text] [Related]
4. Assessment of myeloid-derived suppressor cell differentiation ex vivo.
Blanco E; Escors D; Kochan G
Methods Cell Biol; 2024; 184():85-96. PubMed ID: 38555160
[TBL] [Abstract][Full Text] [Related]
5. Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer.
Li W; Tanikawa T; Kryczek I; Xia H; Li G; Wu K; Wei S; Zhao L; Vatan L; Wen B; Shu P; Sun D; Kleer C; Wicha M; Sabel M; Tao K; Wang G; Zou W
Cell Metab; 2018 Jul; 28(1):87-103.e6. PubMed ID: 29805099
[TBL] [Abstract][Full Text] [Related]
6. IDO1 Expression in Ovarian Cancer Induces PD-1 in T Cells
Amobi-McCloud A; Muthuswamy R; Battaglia S; Yu H; Liu T; Wang J; Putluri V; Singh PK; Qian F; Huang RY; Putluri N; Tsuji T; Lugade AA; Liu S; Odunsi K
Front Immunol; 2021; 12():678999. PubMed ID: 34025677
[TBL] [Abstract][Full Text] [Related]
7. Knock down of APE1 suppressed gastric cancer metastasis via improving immune disorders caused by myeloid-derived suppressor cells.
Zhang B; Tang Q; Shi W; Bao Z; Gao S; Pan C
Cell Cycle; 2024 Mar; 23(5):602-612. PubMed ID: 38717991
[TBL] [Abstract][Full Text] [Related]
8. VISTA promotes the metabolism and differentiation of myeloid-derived suppressor cells by STAT3 and polyamine-dependent mechanisms.
Zhang K; Zakeri A; Alban T; Dong J; Ta HM; Zalavadia AH; Branicky A; Zhao H; Juric I; Husich H; Parthasarathy PB; Rupani A; Drazba JA; Chakraborty AA; Ching-Cheng Huang S; Chan T; Avril S; Wang LL
Cell Rep; 2024 Jan; 43(1):113661. PubMed ID: 38175754
[TBL] [Abstract][Full Text] [Related]
9. The effects of gemcitabine and capecitabine combination chemotherapy and of low-dose adjuvant GM-CSF on the levels of myeloid-derived suppressor cells in patients with advanced pancreatic cancer.
Annels NE; Shaw VE; Gabitass RF; Billingham L; Corrie P; Eatock M; Valle J; Smith D; Wadsley J; Cunningham D; Pandha H; Neoptolemos JP; Middleton G
Cancer Immunol Immunother; 2014 Feb; 63(2):175-83. PubMed ID: 24292263
[TBL] [Abstract][Full Text] [Related]
10. Mechanism study of tyrosine phosphatase shp-1 in inhibiting hepatocellular carcinoma progression by regulating the SHP2/GM-CSF pathway in TAMs.
Wei Q; Luo S; He G
Sci Rep; 2024 Apr; 14(1):9128. PubMed ID: 38644382
[TBL] [Abstract][Full Text] [Related]
11. Tumor-Derived GM-CSF Promotes Granulocyte Immunosuppression in Mesothelioma Patients.
Khanna S; Graef S; Mussai F; Thomas A; Wali N; Yenidunya BG; Yuan C; Morrow B; Zhang J; Korangy F; Greten TF; Steinberg SM; Stetler-Stevenson M; Middleton G; De Santo C; Hassan R
Clin Cancer Res; 2018 Jun; 24(12):2859-2872. PubMed ID: 29602801
[No Abstract] [Full Text] [Related]
12. Myeloid-derived suppressor cells in mammary tumor progression in FVB Neu transgenic mice.
Abe F; Dafferner AJ; Donkor M; Westphal SN; Scholar EM; Solheim JC; Singh RK; Hoke TA; Talmadge JE
Cancer Immunol Immunother; 2010 Jan; 59(1):47-62. PubMed ID: 19449184
[TBL] [Abstract][Full Text] [Related]
13. IDH2/R140Q mutation confers cytokine-independent proliferation of TF-1 cells by activating constitutive STAT3/5 phosphorylation.
Yang J; Chen J; Chang J; Sun X; Wei Q; Cai X; Cao P
Cell Commun Signal; 2024 Feb; 22(1):116. PubMed ID: 38347540
[TBL] [Abstract][Full Text] [Related]
14. Elevated interleukin-27 levels in human neonatal macrophages regulate indoleamine dioxygenase in a STAT-1 and STAT-3-dependent manner.
Jung JY; Gleave Parson M; Kraft JD; Lyda L; Kobe B; Davis C; Robinson J; Peña MM; Robinson CM
Immunology; 2016 Sep; 149(1):35-47. PubMed ID: 27238498
[TBL] [Abstract][Full Text] [Related]
15. Cancer cell genetics shaping of the tumor microenvironment reveals myeloid cell-centric exploitable vulnerabilities in hepatocellular carcinoma.
Ramirez CFA; Taranto D; Ando-Kuri M; de Groot MHP; Tsouri E; Huang Z; de Groot D; Kluin RJC; Kloosterman DJ; Verheij J; Xu J; Vegna S; Akkari L
Nat Commun; 2024 Mar; 15(1):2581. PubMed ID: 38519484
[TBL] [Abstract][Full Text] [Related]
16. PGE(2)-driven induction and maintenance of cancer-associated myeloid-derived suppressor cells.
Obermajer N; Wong JL; Edwards RP; Odunsi K; Moysich K; Kalinski P
Immunol Invest; 2012; 41(6-7):635-57. PubMed ID: 23017139
[TBL] [Abstract][Full Text] [Related]
17. Stat3 Regulates Developmental Hematopoiesis and Impacts Myeloid Cell Function via Canonical and Non-Canonical Modalities.
Sobah ML; Liongue C; Ward AC
J Innate Immun; 2024; 16(1):262-282. PubMed ID: 38643762
[TBL] [Abstract][Full Text] [Related]
18. Triptolide promotes differentiation of human monocytes into immunosuppressive MDSCs.
Wang H; Yang H; Zhang X; Zhou X
Cell Immunol; 2024 May; 401-402():104836. PubMed ID: 38776753
[TBL] [Abstract][Full Text] [Related]
19. Anti-Gr-1 antibody depletion fails to eliminate hepatic myeloid-derived suppressor cells in tumor-bearing mice.
Ma C; Kapanadze T; Gamrekelashvili J; Manns MP; Korangy F; Greten TF
J Leukoc Biol; 2012 Dec; 92(6):1199-206. PubMed ID: 23077247
[TBL] [Abstract][Full Text] [Related]
20. Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function.
Sander LE; Sackett SD; Dierssen U; Beraza N; Linke RP; Müller M; Blander JM; Tacke F; Trautwein C
J Exp Med; 2010 Jul; 207(7):1453-64. PubMed ID: 20530204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]